Within these, the protein Paraoxonase 1 (PON1), an extracellular enzyme for detoxification, immunomodulation and antioxidation in the intestine, had already been found to be downregulated in IBD patients (both CD and UC) in 2009. The gene discussed is PON1; the disease is inflammatory bowel disease.